AU2003267079A1 - Factors that bind intestinal toxins - Google Patents

Factors that bind intestinal toxins

Info

Publication number
AU2003267079A1
AU2003267079A1 AU2003267079A AU2003267079A AU2003267079A1 AU 2003267079 A1 AU2003267079 A1 AU 2003267079A1 AU 2003267079 A AU2003267079 A AU 2003267079A AU 2003267079 A AU2003267079 A AU 2003267079A AU 2003267079 A1 AU2003267079 A1 AU 2003267079A1
Authority
AU
Australia
Prior art keywords
factors
intestinal toxins
bind intestinal
bind
toxins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2003267079A
Other versions
AU2003267079B2 (en
Inventor
Joel Moss
Masatoshi Noda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiba University NUC
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2003267079A1 publication Critical patent/AU2003267079A1/en
Application granted granted Critical
Publication of AU2003267079B2 publication Critical patent/AU2003267079B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003267079A 2002-09-10 2003-09-09 Factors that bind intestinal toxins Ceased AU2003267079B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40974202P 2002-09-10 2002-09-10
US60/409,742 2002-09-10
PCT/US2003/028282 WO2004024070A2 (en) 2002-09-10 2003-09-09 Factors that bind intestinal toxins

Publications (2)

Publication Number Publication Date
AU2003267079A1 true AU2003267079A1 (en) 2004-04-30
AU2003267079B2 AU2003267079B2 (en) 2008-08-14

Family

ID=31993998

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003267079A Ceased AU2003267079B2 (en) 2002-09-10 2003-09-09 Factors that bind intestinal toxins

Country Status (5)

Country Link
EP (1) EP1545209A4 (en)
JP (1) JP2006508924A (en)
AU (1) AU2003267079B2 (en)
CA (1) CA2498225A1 (en)
WO (1) WO2004024070A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1492856A4 (en) 2002-04-05 2010-11-10 Univ Massachusetts Lowell Polymeric antioxidants
EP1776394A2 (en) 2004-07-23 2007-04-25 Polnox Corporation Anti-oxidant macromonomers and polymers and methods of making and using the same
EP1828104A1 (en) 2004-12-03 2007-09-05 Polnox Corporation Synthesis of aniline and phenol-based antioxidant macromonomers and corresponding polymers
US7678877B2 (en) 2004-12-03 2010-03-16 Polnox Corporation Process for the synthesis of polyalkylphenol antioxidants
US7799948B2 (en) 2005-02-22 2010-09-21 Polnox Corporation Nitrogen and hindered phenol containing dual functional macromolecular antioxidants: synthesis, performances and applications
WO2006104957A2 (en) 2005-03-25 2006-10-05 Polnox Corporation Alkylated and polymeric macromolecular antioxidants and methods of making and using the same
WO2006116532A2 (en) 2005-04-28 2006-11-02 University Of Massachusetts Lowell Synthesis of oligo/poly(catechins) and methods of use
US7705176B2 (en) 2005-10-27 2010-04-27 Polnox Corporation Macromolecular antioxidants based on sterically hindered phenols and phosphites
US20070149660A1 (en) 2005-10-27 2007-06-28 Vijayendra Kumar Stabilized polyolefin compositions
WO2007064843A1 (en) 2005-12-02 2007-06-07 Polnox Corporation Lubricant oil compositions
JP4431713B2 (en) 2006-03-07 2010-03-17 学校法人慶應義塾 Conophylline and / or aqueous solution of conophyllidine
WO2008005358A2 (en) 2006-07-06 2008-01-10 Polnox Corporation Novel macromolecular antioxidants comprising differing antioxidant moieties: structures, methods of making and using the same
US7767853B2 (en) 2006-10-20 2010-08-03 Polnox Corporation Antioxidants and methods of making and using the same
JP2012153659A (en) * 2011-01-27 2012-08-16 Akita Univ Humulus lupulus leaf extract and method for producing the same
JP6232177B2 (en) * 2011-11-28 2017-11-15 花王株式会社 Verotoxin deactivator
US10294423B2 (en) 2013-11-22 2019-05-21 Polnox Corporation Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same
US20180251695A1 (en) 2017-03-01 2018-09-06 Polnox Corporation Macromolecular Corrosion (McIn) Inhibitors: Structures, Methods Of Making And Using The Same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2986805B2 (en) * 1989-05-19 1999-12-06 三井農林株式会社 Antitoxin for bacterial exotoxin
US6251461B1 (en) * 1997-10-10 2001-06-26 S. S. Steiner, Inc. Antimicrobial activity of hops extract against Clostridium botulinum, Clostridium difficile and Helicobacter pylori
EP1153604A4 (en) * 1999-02-15 2003-07-30 Nikka Whisky Distilling Co Ltd Adp-ribosylation inhibitors and remedies for endotoxic bacterial enteric infection containing proanthocyanidin as the active ingredient
JP2000342192A (en) * 1999-06-08 2000-12-12 Natl Fedelation Of Agricult Coop Assoc Feed as countermeasure for edema
JP2001249134A (en) * 1999-12-28 2001-09-14 Matsushita Electric Ind Co Ltd Reagent for measuring protein concentration, method for measuring protein concentration using it, and urinalysis
JP4521703B2 (en) * 2000-05-17 2010-08-11 アサヒビール株式会社 Lipase inhibitor obtained from hops

Also Published As

Publication number Publication date
JP2006508924A (en) 2006-03-16
WO2004024070A2 (en) 2004-03-25
EP1545209A4 (en) 2009-07-29
CA2498225A1 (en) 2004-03-25
AU2003267079B2 (en) 2008-08-14
EP1545209A2 (en) 2005-06-29
WO2004024070A3 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
AU2003216341A1 (en) Mhc-peptide complex binding ligands
AU2002247826A1 (en) Specific binding members
AU2003268680A1 (en) Binding tool
AU2003209272A1 (en) Engineered binding proteins
AU2003213647A1 (en) Multimeric binding complexes
AU2003267079A1 (en) Factors that bind intestinal toxins
AU2003272511A1 (en) Cd44-binding ligands
AU2003272902A1 (en) Remedies
AU2002317775A1 (en) Dual cure emulsions
AU2002951388A0 (en) Bookmark
AU2003218885A1 (en) Valuable document
AU2003235325A1 (en) Stapler
AU2003236161A1 (en) Stapler
AU2003261720A1 (en) Stapler
AU2003272901A1 (en) Remedies
EP1544919B8 (en) Triac
AU2003283562A1 (en) Ligands
AU2003243808A1 (en) File mechanism
AU2002367810A1 (en) Bis-transition-metal-chelate-probes
AUPS036402A0 (en) Rhamnose binding protein
AU2003202694A1 (en) Torero protein
AU2003278718A1 (en) Stars-a muscle-specification-binding protein
AU2003221610A1 (en) Stitcher
AU2003205935A1 (en) Forming means
AU2002100840A4 (en) Bookmark

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired